(-)-N-Deacetyl Colchicine

IMPURITIES

Product Details

CAT No.# CS-T-14488
Category Impurities
CAS 3476-50-4
Molecular Weight 357.4
Molecular Formula C20H23NO5
Stock Status: In-Stock
Purity: >98%
Melting Point: 80-85
Solubility: Chloroform, Dichlormethane, DMSO, Methanol
Appearance: Yellow Solid
Synonyms: (10S)-10-amino-3,4,5,14- tetramethoxy2,4,6,11,14-hexaen-13-one
Application Notes: An antimitotic agent that disrupts microtubles by binding to tubulin and preventing its polymerization. Stimulates the intrinsic GTPase activity of tubulin. Induces apoptosis in several normal and tumor cell lines and activates the JNK/SAPK signaling pathway.
References: Sharma, S., et al.: Biochem., 49, 2932 (2010), Bartusik, D., et al.: Bioorg. Chem., 38, 1 (2010), Passarella, D., et al.: Eur. J. Med. Chem., 45, 219 (2010),
Storage: -20°C Freezer, Under Inert Atmosphere
Shipping: Free Shipping for worldwide on order above 2000 USD , Extra charges for Dry ice shipment 80$*
COA / MSDS:    View COA    MSDS
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Benidipine D7
4. Lauroside D
5. Triazolam 13C D3
6. Icatibant impurity 1
7. BISPHENOL AF (RING-13C12)
8. 0.1% TFA in Water ULC-MS
9. Metamizole EP Impurity C HCl
10. Silodosin Metabolite D4
11. Brivaracetam Carboxylic acid metabolite [UCB 42145]
12. Terbuthylazine D5
13. tibolone (848)
14. (Z)-Dimethylvinphos
15. Silodosin Metabolite
16. 2-Phenoxymethanesulfonanilide
17. Nimesulide EP Impurity A
18. Acetone HPLC
19. Nandrolone Decanoate EP impurity F
20. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline


Smileys:
COC(C(OC)=C(OC)C=C1CC[C@H](N)C2=C3)=C1C2=CC=C(OC)C3=O



This page contains information about (-)-N-Deacetyl Colchicine Cas 3476-50-4 and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."